The State of Mental Health M&A

2026 Market Report

Sponsors and strategics are racing to build scaled platforms in a market that is large, underserved and highly fragmented. About 20% of U.S. adults experience a diagnosable mental health condition each year, and U.S. mental health services spending exceeds $280 billion, with 7–9% annual growth expected through 2035. Yet nearly half of those with a diagnosable condition receive no treatment at all.

Three fundamentals are fueling the activity:

• A market built for consolidation. More than 70% of outpatient providers are solo practices or groups with fewer than five clinicians, and no platform holds more than 2–3% national share.

• Demand that outpaces supply. With a shortfall of roughly 30,000 psychiatrists, clinician capacity is the binding constraint, and buyers are increasingly acquiring provider networks to secure it.

• Payor alignment and value-based upside. Untreated populations cost payors about 3x more than treated ones, positioning outcomes-driven providers for value-based and Collaborative Care contracts.

The result is strong buyer demand and premium valuations, with strategic buyers paying the highest prices as health systems, payors and scaled platforms compete for virtual access, interventional modalities and clinician supply.

Inside the report

Our new report, The State of Mental Health M&A, tracks deal activity across five investment cycles, benchmarks valuations by buyer type, and breaks down the operating metrics that separate premium platforms from the rest of the market. It also maps care delivery models across the continuum, highlights notable 2026 deals and public market performance, and includes 60 select mental health transactions from 2025 and 2026 YTD.